Pregio Pharma is actively working toward establishing its own manufacturing facilities as part of its long-term growth strategy. The company plans to develop production sites in various countries, including CIS markets, with further expansion into selected European countries.
This strategic direction reflects Pregio Pharma’s commitment to strengthening its operational capabilities and building sustainable international partnerships.
International Engagement
To support this vision, Pregio Pharma actively participates in international pharmaceutical exhibitions and industry conferences, exploring new markets and building trusted partnerships worldwide.
The management and team of Pregio Pharma participated in the Dubai International Pharmaceuticals & Technologies Conference & Exhibition (DUPHAT 2025), held in January 2025 in Dubai, to explore the international pharmaceutical market and establish new partnerships.
Through continuous global engagement, the company is strengthening its international network and laying the foundation for future manufacturing development.
